Insider · CIK 0001738456

SCHIERMEIER ANDREW

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001738456

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-03	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Operating Officer	AAward	+78.8K sh	—	—	78,750
2021-03-03	NTLAIntellia Therapeutics, Inc. · Restricted Stock UnitA Award	EVP, Chief Operating Officer	AAward	+13.1K sh	—	—	13,125
2021-01-05	NTLAIntellia Therapeutics, Inc.S Sale	EVP, Chief Operating Officer	SSale	−1,377 sh	$55.86	−$76.9K	16,656
2020-12-31	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+4,792 sh	—	—	18,033
2020-12-31	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Operating Officer	AAward	+9,583 sh	—	—	9,583
2020-12-31	NTLAIntellia Therapeutics, Inc. · Restricted Stock Unit (performance-based)A Award	EVP, Chief Operating Officer	AAward	+4,792 sh	—	—	4,792
2020-12-31	NTLAIntellia Therapeutics, Inc. · Restricted Stock Unit (performance-based)M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−4,792 sh	—	—	0
2020-12-30	NTLAIntellia Therapeutics, Inc.M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	+1,500 sh	$13.48	+$20.2K	12,673
2020-12-30	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	EVP, Chief Operating Officer	MExercise/Conversion	−1,500 sh	—	—	148,500
2020-03-02	NTLAIntellia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Operating Officer	AAward	+135K sh	—	—	135,000
2020-01-03	NTLAIntellia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Operating Officer	AAward	+15K sh	—	—	15,000
2019-08-01	NTLAIntellia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, Chief Operating Officer	AAward	+55K sh	—	—	55,000
2019-03-06	NTLAIntellia Therapeutics, Inc.P Purchase	EVP, Chief Operating Officer	PPurchase	+3,250 sh	$16.00	+$52K	3,250
2019-03-06	NTLAIntellia Therapeutics, Inc.P Purchase	EVP, Chief Operating Officer	PPurchase	+4,250 sh	$15.50	+$65.9K	7,500
2018-12-18	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Operating Officer	AAward	+81K sh	—	—	81,000
2018-05-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Operating Officer	AAward	+23.5K sh	—	—	23,500

Recent filings

Accepted (ET)
Mar 54
SCHIERMEIER ANDREW0001209191-21-018326
SEC(opens sec.gov)
Jan 54
SCHIERMEIER ANDREW0001209191-21-001718
SEC(opens sec.gov)
Jan 44
SCHIERMEIER ANDREW0001209191-21-000584
SEC(opens sec.gov)
Mar 44
SCHIERMEIER ANDREW0000899243-20-006973
SEC(opens sec.gov)
Aug 24
SCHIERMEIER ANDREW0001209191-19-044238
SEC(opens sec.gov)
Mar 124
SCHIERMEIER ANDREW0001209191-19-018817
SEC(opens sec.gov)
Dec 204
SCHIERMEIER ANDREW0001209191-18-063663
SEC(opens sec.gov)
May 24
SCHIERMEIER ANDREW0001209191-18-027373
SEC(opens sec.gov)

Companies

Intellia Therapeutics, Inc.EVP, Chief Operating OfficerNTLA

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139